Resources
A wide range of informative monographs, booklets and newsletters; all developed in-house by Cipla.
View allHey there! Welcome!
Get updated on
Select Speciality
Key Trials
Impact of Finerenone & Empagliflozin, in Combination or Alone on UACR in Patients with CKD & T2DM
This study demonstrated that in patients with both CKD & T2DM, initial therapy with a combination of finerenone and empagliflozin resulted in more effective reduction in the UACR in180 days as compared to either of the drugs alone.
Spotlight
Slide Library
Diabetes Mellitus with IgA Nephropathy
A 70-year-old man with long-standing diabetes, HTN, CAD, and latent TB presented with IgA nephropathy. Treated with corticosteroids, isoniazid, and diabetes care, he had reduced proteinuria, improved albumin, stable renal function, and no active TB
Patient Education
View all
